A recent executive order signed Sept. 12 by President Joe Biden aims to bolster the U.S. biotechnology sector, including alternative proteins.
Under administrative agency guidance outlined in the executive order — dubbed the National Biotechnology and Biomanufacturing Initiative — the Biden Administration’s policy aims to coordinate a multiple-agency approach to advance biotechnology and biomanufacturing toward innovative solutions across multiple sectors of the U.S. economy, including food security, agriculture and supply chain resilience.